Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Mao

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Chinese Clinical Oncology|September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case reportBixia Tang, Xinan Sheng, Yan Kong, et al.
British Journal of Cancer|April 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumorsDaphne Day, Vinod Ganju, Ki Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.
Dermatology Practical & Conceptual|February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective StudyYu Du, Zhonghui Qi, Xianbin Liang, et al.
Frontiers in Plant Science|June 30, 2022
Dynamic Quantitative Trait Loci Mapping for Plant Height in Recombinant Inbred Line Population of Upland CottonJing Wu, Lili Mao, Jincai Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
The British Journal of Dermatology|January 23, 2023
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapyLi Zhou, Lizhi Shao, Shunyu Gao, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Chinese Clinical Oncology|September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case reportBixia Tang, Xinan Sheng, Yan Kong, et al.
British Journal of Cancer|April 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumorsDaphne Day, Vinod Ganju, Ki Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.
Dermatology Practical & Conceptual|February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective StudyYu Du, Zhonghui Qi, Xianbin Liang, et al.
Frontiers in Plant Science|June 30, 2022
Dynamic Quantitative Trait Loci Mapping for Plant Height in Recombinant Inbred Line Population of Upland CottonJing Wu, Lili Mao, Jincai Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
The British Journal of Dermatology|January 23, 2023
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapyLi Zhou, Lizhi Shao, Shunyu Gao, et al.
Pageof 15